https://www.onhealthcare.tech/p/when-software-stopped-being-a-labThoughts on Healthcare Markets & Technologyen2026-07-09T16:11:49+00:00When Software Stopped Being a Lab Test: How the CY2027 OPPS Rule’s Software as a Medical Service Category, the O1 Status Indicator, and Pulling Lab AI Off the CLFS Reshape Health Tech Investinghttps://www.onhealthcare.tech/p/reading-the-hhs-fy2027-performanceThoughts on Healthcare Markets & Technologyen2026-07-09T00:42:14+00:00Reading the HHS FY2027 Performance Plan as a Payment Integrity Market Map: Why the Vacated RADV Rule and a $93.5B Improper Payment Pile Separate Incumbent Revenue From Startup Whitespacehttps://www.onhealthcare.tech/p/part-ii-reading-the-hhs-fy2027-performanceThoughts on Healthcare Markets & Technologyen2026-07-09T00:38:31+00:00Part II: Reading the HHS FY2027 Performance Plan as a Payment Integrity Market Map: Why the Vacated RADV Rule and a $93.5B Improper Payment Pile Separate Incumbent Revenue From Startup Whitespacehttps://www.onhealthcare.tech/p/part-i-reading-the-hhs-fy2027-performanceThoughts on Healthcare Markets & Technologyen2026-07-09T00:37:20+00:00Part I: Reading the HHS FY2027 Performance Plan as a Payment Integrity Market Map: Why the Vacated RADV Rule and a $93.5B Improper Payment Pile Separate Incumbent Revenue From Startup Whitespace